Last reviewed · How we verify

Lac-Hydrin — Competitive Intelligence Brief

Lac-Hydrin (AMMONIUM LACTATE) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: alpha-Hydroxy Acid [EPC]. Area: Immunology.

marketed alpha-Hydroxy Acid [EPC] Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Lac-Hydrin (AMMONIUM LACTATE) — Sun Pharma.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Lac-Hydrin TARGET AMMONIUM LACTATE Sun Pharma marketed alpha-Hydroxy Acid [EPC] 1985-01-01
Glycolic Acid 70% Glycolic Acid 70% Combined Military Hospital Abbottabad marketed Alpha-hydroxy acid (AHA) exfoliant
Lactic acid (Dermacid) Lactic acid (Dermacid) Sanofi phase 3 Alpha-hydroxy acid (AHA) / Keratolytic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (alpha-Hydroxy Acid [EPC] class)

  1. Sun Pharma · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Lac-Hydrin — Competitive Intelligence Brief. https://druglandscape.com/ci/ammonium-lactate. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: